A review of tigecycline — the first glycylcycline
- 1 December 2008
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 32, S215-S222
- https://doi.org/10.1016/s0924-8579(09)70005-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A sensitive human bone assay for quantitation of tigecycline using LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2008
- Occurrence of Tetracycline Resistance Genes among Escherichia coli Isolates from the Phase 3 Clinical Trials for TigecyclineAntimicrobial Agents and Chemotherapy, 2007
- A novel antibiotic bone assay by liquid chromatography/tandem mass spectrometry for quantitation of tigecycline in rat boneJournal of Pharmaceutical and Biomedical Analysis, 2007
- Empiric treatment options in the management of complicated intra-abdominal infections.Cleveland Clinic Journal of Medicine, 2007
- Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male SubjectsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline AntimicrobialAntimicrobial Agents and Chemotherapy, 2006
- Antibiotic Coresistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of TigecyclineAntimicrobial Agents and Chemotherapy, 2006
- In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)Diagnostic Microbiology and Infectious Disease, 2005
- Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unitDiagnostic Microbiology and Infectious Disease, 2005
- Considerations in Clinical Trials of Combination Antifungal TherapyClinical Infectious Diseases, 2004